Ranilair Suspension contains Ranitidine, a potent H2 receptor antagonist that reduces the amount of acid produced in the stomach. It is widely used to treat conditions caused by excess stomach acid, such as gastroesophageal reflux disease (GERD), peptic ulcers, and gastritis. By inhibiting the action of histamine on H2 receptors in the stomach lining, Ranitidine reduces acid secretion, which helps alleviate symptoms like heartburn, acid indigestion, and discomfort caused by ulcers.
Ranilair Suspension is an effective solution for treating and preventing conditions such as acid reflux, gastric ulcers, and Zollinger-Ellison syndrome, where the stomach produces excessive acid. It is particularly useful in providing relief from pain, bloating, and irritation caused by gastric acid. Additionally, it may be used in combination with antibiotics for the treatment of Helicobacter pylori infections.
The liquid form of Ranilair Suspension is suitable for pediatric and adult patients who have difficulty swallowing tablets or capsules, offering an easy-to-administer option.